Expert says ‘recent weaknesses in the Hong Kong dollar against other regional currencies’ could help to sustain growth in ...

Jiangsu Hengrui Pharmaceuticals is planning to raise as much as US$1.27 billion via an initial public offering in Hong Kong, joining a wave of Chinese companies seeking to tap the city's market.

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

Singapore-based medical testing firm Mirxes joins Jiangsu Hengrui Pharmaceuticals in revitalised market’s listing surge.

(Reuters) -Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals is seeking to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong initial public offering, according to a ...

In other words, no matter where in the world you purchase gold, the actual value of that gold in US dollars is the same. The below chart shows the annual gold price performance versus various fiat ...

By Rae Wee SINGAPORE (Reuters) -Stocks fell on Thursday while the dollar stumbled as the euphoria from market tailwinds ...

Trump’s tariffs and trade deals continue to affect global markets. Follow along for live updates on the Dow, S&P 500 and Nasdaq.

UBS says wealthy Asian investors are moving away from the US dollar into gold, crypto and Chinese assets, driven by ...

The United States and China have agreed a deal to temporarily slash reciprocal tariffs as the world's two biggest economies ...

President Donald Trump has instilled high tariffs on countries like China, Canada, and Mexico while sparking a trade war with ...